Rac1-GTP levels significantly increased in the tumor tissues of 87 (56%) of the 156 SCC patients compared to adjacent normal tissue, suggesting hyperactivation of Rac1 in tumor tissue. This evidence concerns the gene RAC1 and neoplasm.